Year: 2017
Type: article
Abstract: Motivation: Correct and rapid determination of Mycobacterium tuberculosis (MTB) resistance against available tuberculosis (TB) drugs is essential for the control and management of TB. Conventional molecular diagnostic test assumes that the presence of any well-studied single nucleotide polymorphisms is sufficient to cause resistance, which yields low sensitivity for resistance classification. Summary: Given the availability of DNA sequencing data from MTB, we developed machine learning models for a cohort of 1839 UK bacterial isolates to classify MTB resistance against eight anti-TB drugs (isoniazid, rifampicin, ethambutol, pyrazinamide, ciprofloxacin, moxifloxacin, ofloxacin, streptomycin) and to classify multi-drug resistance. Results: Compared to previous rules-based approach, the sensitivities from the best-performing models increased by 2-4% for isoniazid, rifampicin and ethambutol to 97% (P < 0.01), respectively; for ciprofloxacin and multi-drug resistant TB, they increased to 96%. For moxifloxacin and ofloxacin, sensitivities increased by 12 and 15% from 83 and 81% based on existing known resistance alleles to 95% and 96% (P < 0.01), respectively. Particularly, our models improved sensitivities compared to the previous rules-based approach by 15 and 24% to 84 and 87% for pyrazinamide and streptomycin (P < 0.01), respectively. The best-performing models increase the area-under-the-ROC curve by 10% for pyrazinamide and streptomycin (P < 0.01), and 4-8% for other drugs (P < 0.01). Availability and implementation: The details of source code are provided at http://www.robots.ox.ac.uk/~davidc/code.php. Contact: [email protected]. Supplementary information: Supplementary data are available at Bioinformatics online.
Source: Bioinformatics
Authors: Yang Yang, Katherine E Niehaus, Timothy M Walker, Zamin Iqbal, A Sarah Walker, Daniel J Wilson, Tim E A Peto, Derrick W Crook, E Grace Smith, Tingting Zhu, David A Clifton
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: tuberculosis drug resistance, Mycobacterium tuberculosis, multidrug-resistant tuberculosis, antitubercular agents, isoniazid resistance, rifampicin resistance, ethambutol resistance, pyrazinamide resistance, streptomycin resistance, fluoroquinolone resistance, resistance classification, DNA sequencing data, machine learning classification
Open Access status: hybrid
Estimated APC paid: $3,989
Awards: G1198837610, ASPIRE: Automated Sensing & Predictive Inference for Respiratory Exacerbation, Whole Genome Sequencing as a unified platform for outbreak identification, resistance prediction and virulence profiling in Staphylococcus aureus, G1628705071, NIHR Senior Investigator Award, Machine Learning for Patient-Specific, Predictive Healthcare Technologies via Intelligent Electronic Health Records, G5048751664, NIHR Senior Investigator Award, Statistical methods for analyzing complex genomic variation in human pathogens., Centre for Doctoral Training in Healthcare Innovation, Statistical Methods for Whole Genome Phenotype Mapping in Bacterial Populations.
OpenAlex ID: W2771835478
